BridgeBio Pharma, Inc. (BBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1244470,
    "name": "BridgeBio Pharma, Inc.",
    "stock_name": "BridgeBio Pharma, Inc.",
    "full_name": "BridgeBio Pharma, Inc.",
    "name_url": "stocks-analysis/bridgebio-pharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "74.76",
    "chg": 3.3,
    "chgp": "4.62%",
    "dir": 1,
    "prev_price": "71.46",
    "mcapval": "10,714.69",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US10806X1028",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.03 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bridgebio-pharma-inc-1244470-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $69.48, Up 139.38%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-6948-up-13938-3659207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3659207.png",
        "date": "2025-10-30 18:51:02",
        "description": "BridgeBio Pharma, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock performance over the past year. The company, with a market capitalization of USD 10,715 million, showcases strong operational efficiency despite being currently loss-making, highlighted by its notable return on equity."
      },
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $57.49, Up 103.49%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-5749-up-10349-3626671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3626671.png",
        "date": "2025-10-16 18:29:00",
        "description": "BridgeBio Pharma, Inc. achieved a new 52-week high of USD 57.49 on October 15, 2025, reflecting a substantial increase over the past year. With a market capitalization of USD 10,715 million, the company has a strong return on equity but is currently loss-making, as indicated by its financial metrics."
      },
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $57.47, Up 103%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-5747-up-103-3622834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3622834.png",
        "date": "2025-10-15 17:11:37",
        "description": "BridgeBio Pharma, Inc. achieved a new 52-week high of USD 57.47 on October 14, 2025, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has seen significant growth over the past year, with a notable return on equity and unique financial metrics despite being loss-making."
      },
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $56.24, Up 101% Yearly",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-5624-up-101-yearly-3620156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3620156.png",
        "date": "2025-10-14 18:57:17",
        "description": "BridgeBio Pharma, Inc. achieved a new 52-week high of USD 56.24 on October 13, 2025, reflecting a substantial increase over the past year. The company, with a market capitalization of USD 10,715 million, has shown strong financial metrics despite being currently loss-making and navigating a competitive industry landscape."
      },
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $55.33, Up 98.71%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-5533-up-9871-3608078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3608078.png",
        "date": "2025-10-09 20:27:09",
        "description": "BridgeBio Pharma, Inc. achieved a new 52-week high on October 8, 2025, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has seen significant growth over the past year, with a notable return on equity, despite currently operating at a loss and lacking a dividend yield."
      },
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $55.13, Up 94.83%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-5513-up-9483-3604397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3604397.png",
        "date": "2025-10-08 16:58:36",
        "description": "BridgeBio Pharma, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector with a notable increase over the past year. The company, with a market capitalization of USD 10,715 million, is currently loss-making but has demonstrated impressive financial metrics."
      },
      {
        "title": "BridgeBio Pharma Hits New 52-Week High of $54.64, Up 96.23%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharma-hits-new-52-week-high-of-5464-up-9623-3601700",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_priceRelatedfactors_3601700.png",
        "date": "2025-10-07 22:01:55",
        "description": "BridgeBio Pharma, Inc. recently achieved a new 52-week high, reflecting a substantial increase in its stock price over the past year. The company, operating in the Pharmaceuticals & Biotechnology sector, has shown strong financial metrics despite being loss-making, with a notable market capitalization and significant upward movement from its previous low."
      },
      {
        "title": "BridgeBio Pharma, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bridgebio-pharmas-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-strong-performance-3601320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BridgeBioPharma_technicaldot_3601320.png",
        "date": "2025-10-07 20:50:52",
        "description": "BridgeBio Pharma, Inc. has recently revised its evaluation amid changing market dynamics. The company has shown remarkable performance over the past year, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, while the stock has reached a 52-week high, reflecting strong momentum and strategic positioning in biotechnology."
      },
      {
        "title": "Is BridgeBio Pharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bridgebio-pharma-inc-technically-bullish-or-bearish-3599329",
        "imagepath": "",
        "date": "2025-10-07 12:24:13",
        "description": "As of 3 October 2025, the technical trend for BridgeBio Pharma, Inc. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the KST shows a mildly bearish signal. The daily moving averages are bullish, supporting the mildly bullish trend. The Dow Theory also reflects a mildly bullish outlook on both weekly and monthly timeframes. \n\nIn terms of performance, the stock has significantly outperformed the S&P 500 year-to-date with a return of 99.02% compared to 14.18%, and over the past year with a return of 116.45% against 17.82%. Overall, the current technical stance is mildly bullish, driven primarily by the bullish indicators in MACD and Bollinger Bands...."
      }
    ],
    "total": 22,
    "sid": "1244470",
    "stock_news_url": "https://www.marketsmojo.com/news/bridgebio-pharma-inc-1244470"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

BridgeBio Pharma Hits New 52-Week High of $69.48, Up 139.38%

2025-10-30 18:51:02

BridgeBio Pharma, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock performance over the past year. The company, with a market capitalization of USD 10,715 million, showcases strong operational efficiency despite being currently loss-making, highlighted by its notable return on equity.

BridgeBio Pharma Hits New 52-Week High of $57.49, Up 103.49%

2025-10-16 18:29:00

BridgeBio Pharma, Inc. achieved a new 52-week high of USD 57.49 on October 15, 2025, reflecting a substantial increase over the past year. With a market capitalization of USD 10,715 million, the company has a strong return on equity but is currently loss-making, as indicated by its financial metrics.

BridgeBio Pharma Hits New 52-Week High of $57.47, Up 103%

2025-10-15 17:11:37

BridgeBio Pharma, Inc. achieved a new 52-week high of USD 57.47 on October 14, 2025, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has seen significant growth over the past year, with a notable return on equity and unique financial metrics despite being loss-making.

BridgeBio Pharma Hits New 52-Week High of $56.24, Up 101% Yearly

2025-10-14 18:57:17

BridgeBio Pharma, Inc. achieved a new 52-week high of USD 56.24 on October 13, 2025, reflecting a substantial increase over the past year. The company, with a market capitalization of USD 10,715 million, has shown strong financial metrics despite being currently loss-making and navigating a competitive industry landscape.

BridgeBio Pharma Hits New 52-Week High of $55.33, Up 98.71%

2025-10-09 20:27:09

BridgeBio Pharma, Inc. achieved a new 52-week high on October 8, 2025, reflecting its strong performance in the pharmaceuticals and biotechnology sector. The company has seen significant growth over the past year, with a notable return on equity, despite currently operating at a loss and lacking a dividend yield.

BridgeBio Pharma Hits New 52-Week High of $55.13, Up 94.83%

2025-10-08 16:58:36

BridgeBio Pharma, Inc. has achieved a new 52-week high, reflecting its strong performance in the pharmaceuticals and biotechnology sector with a notable increase over the past year. The company, with a market capitalization of USD 10,715 million, is currently loss-making but has demonstrated impressive financial metrics.

BridgeBio Pharma Hits New 52-Week High of $54.64, Up 96.23%

2025-10-07 22:01:55

BridgeBio Pharma, Inc. recently achieved a new 52-week high, reflecting a substantial increase in its stock price over the past year. The company, operating in the Pharmaceuticals & Biotechnology sector, has shown strong financial metrics despite being loss-making, with a notable market capitalization and significant upward movement from its previous low.

BridgeBio Pharma, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-07 20:50:52

BridgeBio Pharma, Inc. has recently revised its evaluation amid changing market dynamics. The company has shown remarkable performance over the past year, significantly outperforming the S&P 500. Technical indicators present a mixed outlook, while the stock has reached a 52-week high, reflecting strong momentum and strategic positioning in biotechnology.

Is BridgeBio Pharma, Inc. technically bullish or bearish?

2025-10-07 12:24:13

As of 3 October 2025, the technical trend for BridgeBio Pharma, Inc. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the KST shows a mildly bearish signal. The daily moving averages are bullish, supporting the mildly bullish trend. The Dow Theory also reflects a mildly bullish outlook on both weekly and monthly timeframes. In terms of performance, the stock has significantly outperformed the S&P 500 year-to-date with a return of 99.02% compared to 14.18%, and over the past year with a return of 116.45% against 17.82%. Overall, the current technical stance is mildly bullish, driven primarily by the bullish indicators in MACD and Bollinger Bands....

View All News